Draft Guidance for Industry on Labeling of Over-the-Counter Human Drug Products Using a Column Format; Availability

Riepilogo

The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled ``Labeling of Over-the-Counter Human Drug Products Using a Column Format.'' This draft guidance is intended to provide information on the use of columns as part of the standardized format and standardized content requirements for the labeling of over-the-counter (OTC) drug and drug- cosmetic products.